A Food and Drug Administration (FDA) expert panel has reignited a debate over whether hormone therapy should be used to treat ...

The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and ...

A panel of 12 experts in the menopause field reexamined the findings of the 2002 Women’s Health Initiative study that said ...

The FDA is reconsidering the black box warning on estrogen. Experts say it’s time for a change—find out what this means for ...

Experts worry the warning on vaginal estrogen menopause treatments is doing more harm than good and is not supported by science.

Bypassing its standard pathways for scientific discussions, FDA has recently held a slew of so-called "expert panels" that ...

The debate over whether to use hormone therapy to treat menopausal women continues, as a Food and Drug Administration (FDA) expert panel weighs in. The panel, consisting […] ...

Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...

While Astellas’ Veozah was the first neurokinin 3 (NK-3) receptor antagonist approved for menopause, Lynkuet is the first ...

A more complex story about menopausal hormone therapy has emerged in recent years, along with a careful review of the conclusions that led ... In 2023, the Food and Drug Administration approved ...

A decades-old label has scared women (and their doctors) away from safe and effective menopause treatment. That could finally change today.